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TerminationThe messenger RNAs containing the thirteen protein coding sequences of the human mitochondrial genome
have frequently been regarded as a single functional category, alike in arrangement and hence in mode of
expression. The “generic” mitochondrial mRNA is perceived as having (i) an arrangement within the
polycistronic unit that permits its liberation following mt-tRNA processing, (ii) no 5′ cap structure or introns,
(iii) essentially no untranslated regions, and (iv) a poly(A) tail of approximately ﬁfty nucleotides that is
required in part to complete the termination codon. Closer inspection reveals that only two molecules ﬁt this
pattern. This article examines the extent to which human mitochondrial mRNA species differ from one
another.RNA; mtDNA, mitochondrial
gion; nt, nucleotide
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Evolution from being an intracellular parasite to an organelle has
resulted in a reduced humanmitochondrial genome that now encodes
a mere 37 genes; 13 of these encode proteins, these are in addition to
the complete set of 22 mitochondrial (mt-)tRNAs and the 2
mitochondrial (mt-)rRNAs that are required for their expression [1].
All 13 of these mitochondrially expressed proteins are indispensable
polypeptides of the inner membrane multi-subunit complexes I, III, IV
and V that couple oxidative phosphorylation. The genes that encode
the remainder (greater than 99%) of the mitochondrial proteome are
encoded by the nucleus.
Great progress has beenmade over the past 15°years in characteris-
ing the molecular mechanisms and key players underlying mammalian
mitochondrial transcription (detailed in [2]). This article, however, is
more concerned with the mitochondrial (mt)-mRNAs themselves and
exploring cis-acting elements in these RNA units. All mt-mRNAs are
produced from large polycistronic RNA. To generate these polycistronic
molecules, the genome (mtDNA, Fig. 1A) is transcribed from both
strands in almost its entirety. Historically, the two strands of mtDNA
have been referred to as theheavy (H-) and light (L-) strands dependent
on their buoyancy in CsCl density gradients. Thus, transcription from the
H-strand results in an RNA unit that is processed into 2 mt-rRNAs, 14
mt-tRNAs and mt-mRNAs that encode 12 proteins. Conversely,transcription of the L-strand produces RNA that is cleaved to produce
8 mt-tRNAs and only 1 mt-mRNA that encodes a single protein.
Promoters that are found in the mtDNA non-coding region recruit
mitochondrial RNApolymerase todrive this transcription, leading to the
production of three polycistronic transcription units; two originating
from the heavy strand promoter that initiate at independent sites (H1
and H2) and one from the light strand promoter (LSP) (Fig. 1B).
Polycistronic RNA initiating fromH1 starts upstream ofMT-TF, the gene
encoding mt-tRNAPhe and has a deﬁned termination site withinMT-TL1
(mt-tRNALeu(UUR)). The longer transcription unit initiates at H2, close to
the start of MT-RNR1 (gene encoding the 12 S mt-tRNA) and extends
throughout the entire downstream coding region of the genome. In
exponentially dividing HeLa cells, initiation at H1 is favoured ﬁfty to
hundred times over initiation at H2 [3,4]. Termination of the shorter
transcript is believed to be mediated by binding of mTERF, the ﬁrst
identiﬁed member of the mTERF protein family [5–7]. Transcription
driven from LSP generates the second long polycistronic unit [8]. The
termination site for neither of the long polycistronic RNA units has been
precisely mapped ([2], Fig. 1B). Further, these two long polycistronic
transcripts are generally not observed as full length units under
experimental conditions, indicating that transcript cleavage occurs
concurrently or rapidly after synthesis [9]. Cleavage is not 100% efﬁcient
at all sites and unprocessed forms can be found in wild type cells (see
below). The efﬁciency of cleavage may be affected by tissue type or by
mutations that cause sequence alterations [10]. Additional RNA species
that are rarely observed at steady state bynorthern analysis are the anti-
sense transcripts [11] and RNA corresponding to the entire noncoding
region [12].
As mentioned above, the general view of a typical human mt-
mRNA is that of a molecule that is liberated by the processing of
Fig. 1.Map of humanmitochondrial DNA and the RNA transcription units that are generated. (A) The humanmitochondrial genome encodes 37 genes. Circles represent the 22 genes
encoding mt-tRNAs depicted by their single letter code; the 13 genes encoding mt-mRNA and 2 mt-rRNA indicated using the nomenclature given on Mitomap (http://www.
mitomap.org). The initiating/promoter positions of the polycistronic transcription units H1, H2 and LSP within the non-coding region (NCR) are indicated. (B) Transcription map of
the human mitochondrial genome. The three polycistronic RNA units generated by transcription initiating at H1, H2 or produced from the Light Strand Promoter (LSP), are
represented here in a linear fashion. The shortest of these commences from H1, with well-deﬁned start and stop sites initiating upstream ofMT-TF and terminating part way through
MT-TL1 [2]. The long transcription unit from H2 incorporates MTRNR1 and extends through the genome, terminating downstream of MT-TT. Transcription from LSP generates the
second of the long unit that also extends throughout the genome, terminating downstream ofMT-TP, however there is no consensus on the ﬁnal termination site for either of the long
polycistronic units [2], which are represented by dashed lines. RNA sequences are represented as follows; mt-rRNAs as hashed boxes, mt-mRNAs as black boxes and mt-tRNAs as
circles. Nomenclature of each mt-mRNA or mt-rRNA corresponds to the gene nomenclature as described above, except for the two bicistronic RNA units RNA7 and RNA14 that
encodes the proteins ND4L/ND4 and ATPase8/6, respectively.
1082 R.J. Temperley et al. / Biochimica et Biophysica Acta 1797 (2010) 1081–1085upstream and downstream mt-tRNAs, lacks both 3′ and 5′ untrans-
lated regions (UTRs), contains no introns, lacks any cap or modiﬁca-
tion at the 5′ end and is polyadenylated to approximately ﬁfty
residues at the 3′ terminus to allow completion of the stop codon. In
fact only two of the human mitochondrial transcripts resemble this
description,MT-ND2 andMT-ND3. Although mt-mRNAs as a group do
share particular features that mark them as different from cytosolic
mRNAs, they also exhibit signiﬁcant variability as a class. This article
outlines the principal characteristics of humanmitochondrial mRNAs;
their similarities and how they differ.
2. Not all mt-mRNAs are produced by processing of mt-tRNAs
from a polycistronic RNA unit
Traditionally, mt-tRNA folding and cleavage is described as the
nucleation event that releases the mt-mRNAs from the long
polycistronic transcripts [9]. A minimum of forty-three cleavage
events would be required to liberate all of the mt-mRNAs, mt-tRNAs
and mt-rRNAs, however, not all of these cleavages can be accounted
for by mt-tRNA processing. No sequence similarity is evident in these
cut sites that might direct recognition by processing or maturation
machinery [1]. Various observations of transcription units, including
those incorporating the open reading frame (ORF) encoding ND6 [13–
16], imply that a number of cleavage events routinely take place that
would not be accounted for by the mt-tRNA punctuation model,
originally proposed by Ojala et al. [9]. Irrespective, this model does
still satisfy the majority of processing events. The trans-acting factorthat is responsible for the 5′ processing had long been a source of
debate. After many years of controversy, however, Rossmanith and
colleagues have now fully characterised mitochondrial RNase P, its
protein-only components and its role in mt-tRNA processing [17],
although the possibility of a second, RNA containing, mitochondrial
RNase P with differing substrate speciﬁcity has not been ruled out. An
RNase Z, presumably ELAC2 (RNZ2), is proposed to resolve the 3′ end
of the mt-tRNA [18], although this activity has yet to be formally
attributed to ELAC2 in human mitochondria.
Mitochondrial mRNA transcription units were ﬁrst identiﬁed by
the afﬁnity of their poly(A) tails to oligo dT columns and were
numbered 1 to 18 by size [9,19]. Since then the nomenclature has
become somewhat varied so this report will use the current system
favoured by MitoMap (http://www.mitomap.org). The exception to
this is the terminology for the 2 transcription units that remain as
bicistronic elements containing overlapping open reading frames
encoding ATPase8 and ATPase6, or ND4L and ND4. The original names
given to these bicistronic species were RNA14 and RNA7, respectively
and have not been superseded. Although several of the original
species 1–18 were identiﬁed as unprocessed molecules, it remains
uncertain whether some of these species represent true precursors or
products of imperfect cleavage. Such species include those of various
lengths that contain the open reading frame for ND6 orMT-CO1+OriL
but have very low steady state levels and so although present are
rarely detected by standard methods [11]. It should, however, be
noted that there are several persistent and uncleaved intermediates
that are readily observable at steady state by simple northern analysis.
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immediately by MT-CO3 with no intervening tRNA. The second,
RNA19, contains uncleaved 16 S mt-rRNA, mt-tRNALeu(UUR) and MT-
ND1.
3. How similar is the polyadenylation status of mt-mRNA species?
Upon processing, there is rapid constitutive polyadenylation of the
3′ terminus of mt-mRNAs [9,18]. Indeed, the ﬁrst detectable
mitochondrial transcripts following release from transcription inhi-
bition all carry poly(A) 3′ extensions [20]. This also suggests that
polyadenylation is a single processive event.
This maturation event captures the site of cleavage, which can be
revealed by RT-PCR, cloning and sequencing. From these data, it is
apparent that processing of several RNA species in cultured cells is
reproducibly error prone. For example, in 20% of clones containing
MT-CO2 and 5% of MT-ND3, the terminal mtDNA-encoded residue(s)
were missing ([21] and RJT, unpublished observation). Circularisation
assays were used to analyse mt-tRNAArg, which is immediately
downstream of MT-ND3. This revealed additional residues that
correspond to upstream nucleotides that are lost from the 3′ terminus
of MT-ND3. The loss of the terminal 3′ residues of these mt-mRNAs,
however, does not prevent normal polyadenylation. Further, when
mt-mRNAs are endonucleolytically cleaved in vivo, the truncated
species are immediately readenylated [22]. This is also consistent with
a previous observation in a ﬁbroblast cell line derived from a patient
with a microdeletion at the 3′ terminus of RNA14 [20]. Although
shortened on translation, the transcripts lacking termination codons
were initially matured with poly(A) tails, making them indistinguish-
able from those seen in control cells.
Mitochondrial poly(A) tail (MPAT) assays, as described in Ref. [20],
have been devised for all human mitochondrial mRNAs with the
exception of MT-ND6, for which a single consistent 3′ end has not be
identiﬁed [16]. For the majority of the remaining mt-mRNA species
there is a single major population that spans approximately 10
residues, with a median of around 45 nt (Table 1). There is however, a
slight variation between cell types (Fig. 2A) as well as between
transcripts within a cell type (Fig. 2B). On closer examination it is
evident that poly(A) tail lengths of speciﬁc transcripts are not
consistent between cell types. Moreover, certain mt-mRNAs bear 2
relatively abundant longer populations as seen onMT-CO1,which has
medians of approximately 37 and 52 nt. A less dramatic example,MT-
CO3, has median lengths of 42 and 57 nt (Fig. 2A). In Hep G2 and 143B
cells the shorter tail dominates in contrast to ﬁbroblasts where it is the
longer form that is in the greatest abundance; species spanning bothTable 1
Features of human mitochondrial transcripts.
Protein 5′ Leader (nt) Open reading framea 3′ Trailer (nt) Initiation codon
ND5 0 1811 568 AUA
COX1 3 1541 72 AUG
ND4 296 1377 0 AUG
CYTB 0 1140 0 AUG
ND2 0 1041 0 AUU
ND1 2 955 0 AUA
COX3 0 783 0 AUG
COX2 0 708 24 (15)b AUG
ATP6 161 679 0 AUG
ND6 0 524 ?e AUG
ND3 0 345 0 AUA
ND4L 0 296 1371 AUG
ATP8 1 206 634 AUG
a Protein coding sequences are ranked by length of open reading frame. Sequences taken
b The 3′ UTR of MTCO2 contains a deletion of 9 residues in HepG2 cells.
c As re-assigned in Temperley et al. [18].
d Poly(A) tail lengths were determined by MPAT in Hep G2 cells.
e There is no current consensus on the deﬁned end of transcript MTND6 [16].populations are visible in neuroblastoma (SHSY5Y) and HeLa cells.
When such a bipartite distribution exists, this size difference of 15–17
nucleotides between the two populations is also not conserved.
Perhaps the most strikingly divergent from the other human mt-
mRNAs is that ofMT-ND5. Although there are longer species averaging
∼25 or 35 nt, the major population is oligo- rather than polyadeny-
lated, with an extension of between 0 and 10 nt in length, zero being
the most frequently occurring (Fig. 2B). This is in line with the
observations of Slomovic et al. [16] where they detect relatively little
polyadenylation at this site. Although there is a broadly similar proﬁle
for MT-ND5 in HeLa, 143B and neuroblastoma cells, in HEK293 cells
there is very little evidence of oligo-adenylated species and the
dominant population has a median of 40 nt. Thus highlighting that
there are differences in the length of poly(A) extensions both between
transcripts within a cell type and also for the same transcript between
cell types.
The 3′ termini of the 12S and 16S mt-rRNA species are discernibly
different from the mt-mRNAs. Sequence analysis of clones generated
by ligation-mediated RT-PCR reveals that in the majority of cases
there is no evidence for the addition of more than 3–4 nt to 12 S rRNA
in Hep G2 cells or ﬁbroblasts (RJT, unpublished observation). The 3′
cleavage site of 12 S mt-rRNA is as predicted by the mtDNA sequence,
although marginally truncated forms have been observed. Unexpect-
edly, the majority of 16 S clones carry residues from the downstream
mt-tRNALeu(UUR), this is perhaps as a consequence of transcription
termination at this point rather than mis-processing. Given reports by
other authors, it seems likely that sub-populations of more exten-
sively polyadenylated mt-rRNAs do or can exist but this does not
appear to be the predominant form under normal growth conditions
in cultured cells [16].
4. Do mt-mRNAs contain untranslated regions and do these have
known functions?
Human mt-mRNAs are generally described as having essentially
no untranslated regions (UTR). However, there are only 4 RNA species
that have no ﬂanking untranslated regions of any kind in humans
(Table 1);MT-CO3, MT-CYB, MT-ND2, andMT-ND3. Thus, UTRs do exist
on human mt-mRNAs but can be as short as 1, 2 or 3 nucleotides, as
seen in the 5′UTRs of RNA14,MT-ND1 andMT-CO1 respectively. There
are two 5′UTRs that are found preceding either the ORF encoding ND4
or the ORF for ATPase6. Both of these ORFs constitute the downstream
part of bicistronic transcripts RNA14 and RNA7, respectively, and
hence the 5′UTR is in fact the out of frame sequence encoding each of
the upstream ORFs. In reciprocal fashion, part of the downstream ORFTermination codon “A” additions required for stop codon Poly(A) tail lengthd
UAA 0 0/8
UAGc 0 37
UAA 2 48
UAA 2 40
UAA 2 43
UAA 1 45
UAA 2 43
UAG 0 45
UAA 1 45
UAGc 0 -
UAA 2 44
UAA 0 48
UAG 0 45
from Ref. [1].
Fig. 2. Poly(A) proﬁles vary between cultured cell types and between transcripts. Panel A shows an MPAT assay for MT-CO3 transcripts in a variety of cell types including primary
ﬁbroblasts, Hep G2, 143B osteosarcoma, neuroblastoma (SHSY5Y) and HeLa. Negative controls for the ﬁrst and second PCR steps are always performed. Panel B indicates the
variation in poly(A) tail length between different human mt-transcripts at steady state in Hep G2 cells. Transcripts are aligned at the zero 3′ extension (0); nucleotide positions of 0,
10, 25 and 50 3′ extensions are indicated. The MPAT methodology was performed as described in Ref. [20].
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MT-CO2 also possesses a 3′UTR but this is not fully conserved between
species and is the only UTR longer than three residues to consist of
sequence with no known additional purpose. The remaining 3′UTRs
consist of either anti-sense of coding sequences (following MT-CO1,
MT-ND6 or MT-ND5) or overlapping open reading frames (RNA7,
RNA14 as described above). This is signiﬁcant as it suggests that any
elements required to stimulate cleavage, polyadenylation or transla-
tion would have to be contained within coding sequences (sense or
anti-sense) and have to be reconciled with mt-tRNA structures or the
amino acid content of proteins.
5. Codon usage to start and stop translation
In 8 of the 13 ORFs, the initiation codon starts at the very 5′
terminal nucleotide of the mt-mRNA, in 3 cases translation initiates a
few (b4) nucleotides down from the 5′ terminal nucleotide and as
described above, the remaining 2 ORFs are embedded in the mature
mt-mRNA as they constitute the downstream coding sequences of the
bicistronic transcripts. While AUG is the most common initiation
codon, occurring in nine instances, AUA and AUU are also used
(Table 1). Hence, it appears likely that there must be recognisable and
distinctive features that facilitate loading of the mitoribosomes to the
correct start site for translation initiation. Spremulli and colleagues
[23] used chemical characterisation of the 5′ sequences and identiﬁed
a lack of secondary structure that could more easily permit
mitochondrial ribosome loading. No sequences or structures in UTRs
or ORFs have been identiﬁed as having a role in recruitment or
assembly of mitochondrial ribosomes, however it is likely such
elements must exist, given the variation in initiation codons and their
positions. Such an association is suggested for TACO1, the ﬁrst
translational activator for a humanmt-mRNA, wheremutations in this
protein cause speciﬁc reduction in the protein synthesis of COX1 [24].
There is no correlation between use of an unconventional ini-
tiation codon and possession of a 5′ UTR. In contrast, non-UAA
termination codons are always followed by a 3′ UTR in human mt-
mRNA. Until recently, no functional signiﬁcance has been attached to
this. In humans, UAA terminates nine open reading frames. Of theremaining four, two end in UAG. AGA/AGG were also designated as
stops in the 1981 sequencing of the humanmitochondrial genome [1].
Recent data have now shown that the AGA/AGG triplets are not
classical stop codons that are recognised by the mitochondrial release
factor mtRF1a, but instead contribute to a −1 frameshift. This
repositioning of the mitochondrial ribosome on the mt-mRNA results
in a UAG occupying the A-site, which then acts as a termination signal
in these two cases [22]. For this−1 frameshift to transpire, the 3′UTR
plays a crucial role. The downstream 3′UTR sequence forms a strong
secondary structure that inhibits any potential readthrough. Codons
AGA or AGG in the A site would not be recognised by the
mitochondrial release factor or any mt-tRNA. The secondary structure
generated within the 3′UTR immediately downstream of the AGA/G
therefore acts in conjunction with the “unrecognised” AGA/G forcing
the ribosome to reposition and allow the standard UAG stop codon to
be recognised by the mitochondrial release factor, mtRF1a [22,25].
In summary, each mt-transcription unit must contain cis-acting
elements that promote cleavage, allow subsequentmaturation and for
mt-mRNA, translation. The speciﬁc nature of the elements that recruit
the required trans-acting factor(s) or indeed many of the trans-acting
factors themselves have yet to be fully characterised. The assortment
of initiation codons and variety of their locations within RNA
molecules suggests a role for additional factors that can steer
mitochondrial ribosomes to appropriate locations. Although not
discussed above, elements necessary for maintenance and replication
of mtDNA, or coupling transcription to translation may also be
encrypted in the transcript [26]. The scarcity of genuinely untrans-
lated regions in mt-mRNAs necessitates an overlayering of functions
to a single sequence, which would enforce constraints on a genome
generally perceived to be relatively permissive to mutation.
6. Concluding remarks
The apparent simplicity of the human mitochondrial genetic
system may lead one to suspect that there are generic mechanisms of
RNA cleavage, maturation, translation and degradation. At a mecha-
nistic level this may be true, however, the cis-acting elements that
direct and promote these processes appear to vary. The transcript
1085R.J. Temperley et al. / Biochimica et Biophysica Acta 1797 (2010) 1081–1085descriptions given here are not comprehensive, but it is clear that
there is a lack of homogeneity between human mt-mRNAs and an
absence of obvious features carried by all species. Not even poly(A)
tails can be shown to be present on all mRNAs; where present they
vary substantially in length, for reasons that remain to be determined,
and can also be found on molecules where stability or translation
would not appear to be desirable. Recent evidence of polyuridylation
of transcripts further complicates any simplistic interpretation [27].
Hence, it appears that human mitochondrial mRNAs, like members of
all families, are similar but different.
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